Skip to Content

Join the 'Naltrexone' group to help and get support from people like you.

Naltrexone News

Meds Can Cut Deaths From Opioid Abuse, But Too Few Get Them

Posted 18 Jun 2018 by Drugs.com

MONDAY, June 18, 2018 – Buprenorphine and methadone can cut the chances that someone who survives an opioid overdose will succumb to yet another one, but too few patients get the treatments, a new study shows. "We have two drugs that are lifesaving for people who have had an overdose," said lead researcher Dr. Marc Larochelle, a general internist and researcher at Boston Medical Center's Grayken ...

Top Meds To Treat Opioid Addiction Equally Safe, Effective

Posted 15 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 15, 2017 – The top two medications used to treat opioid addiction appear equally safe and effective, a new study finds. With the United States in the midst of an unprecedented opioid crisis, researchers conducted a head-to-head trial of two leading addiction treatments – naltrexone (Vivitrol) and buprenorphine-naloxone (Suboxone). "The newer drug, naltrexone, was as effective in ...

Drug OD Rate Now Higher in Rural U.S. Than Cities: CDC

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – Drug overdose death rates in rural areas of the United States are now higher than in cities, a trend that worries federal health officials. In 2015, drug overdose was the leading cause of injury-related death in the United States – with 52,000 fatalities attributed to opioid painkillers, heroin and other potentially deadly drugs, researchers said in a new report. U.S. ...

Opioid Abuse Jumps 6-Fold for U.S. Youth, Too Few Get Treated: Study

Posted 19 Jun 2017 by Drugs.com

MONDAY, June 19, 2017 – The rate of opioid addiction among Americans age 25 and under rose nearly sixfold from 2001 to 2014. But few young addicts get medical treatment that might prevent overdose or relapse, a new study finds. Only about 27 percent of youths treated for addiction to prescription painkillers or heroin receive either buprenorphine or naltrexone, two recommended anti-addiction ...

5 Diet Drugs: Which Ones Work?

Posted 14 Jun 2016 by Drugs.com

TUESDAY, June 14, 2016 – Any of the prescription weight-loss drugs on the market can help obese people shed pounds, although some seem more effective than others, a new study finds. Currently, five drugs are approved in the United States for managing obesity. But little has been known about how they stack up against one another, said Dr. Siddharth Singh, the lead researcher on the new study. The ...

3 in 10 Americans Have Drinking Problem at Some Point in Their Lives

Posted 3 Jun 2015 by Drugs.com

WEDNESDAY, June 3, 2015 – Nearly 30 percent of Americans have a problem with alcohol at some point in their lives, ranging from binge drinking to full-blown alcoholism, but less than 20 percent are ever treated, a new study found. Alcohol use disorders are among the most common mental health problems worldwide and result in disability, illness and death, researchers from the U.S. National ...

FDA Approves New Obesity Drug Contrave

Posted 12 Sep 2014 by Drugs.com

THURSDAY, Sept. 11, 2014 – The U.S. Food and Drug Administration's approval of a new weight-loss drug on Wednesday marks the third time the agency has given its blessing to a new diet medication since 2012. Called Contrave, the medicine is a combination of two approved drugs: naltrexone, which treats alcohol and drug addiction, and bupropion, which treats depression and seasonal affective ...

Novel Weight-Loss Drug Contrave Is Approved

Posted 12 Sep 2014 by Drugs.com

THURSDAY, Sept. 11, 2014 – A new weight-loss medication for the overweight and obese has been approved by the U.S. Food and Drug Adminstration. Contrave is a combination of two already-approved drugs, naltrexone and bupropion, in extended-release form. The former is approved to treat alcohol or opioid dependence, while the latter is approved for depression, seasonal affective disorder and as a ...

FDA Approves Contrave (bupropion/naltrexone) for Weight Management

Posted 12 Sep 2014 by Drugs.com

September 10, 2014 – The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obesity) or adults with a BMI of 27 ...

FDA Approves Vivitrol to Treat Opioid-dependent Patients

Posted 13 Oct 2010 by Drugs.com

ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Drug Administration today approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment. Vivitrol is an extended-release formulation of naltrexone administered by intramuscular injection once a month. Naltrexone works to block opioid receptors in the brain. It blocks the effects of ...

Ask a Question

Further Information

Related Condition Support Groups

Alcohol Dependence, Opiate Dependence, Fibromyalgia, Trichotillomania, Smoking Cessation

Related Drug Support Groups

Vivitrol, Revia, Depade

Naltrexone Patient Information at Drugs.com